June 15, 2004
Early Data Shows Steroid-Free Protocol May Be Safe with Low Rejection Rates CTI Clinical Trial and Consulting Services announced that Goran Klintmalm, M.D., Ph.D., chief of Baylor Regional Transplant Institute and principle investigator of a study comparing 3 immunosuppressant treatment regimens in liver transplant recipients with hepatitis C, presented ...
Read More